Clinical trial
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell…
NCT00003146 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003146 |
|---|---|
| Title | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma |
| Official title | A Phase II Trial of Thiotepa, Busulfan, and Melphalan Followed by Autologous or Syngeneic Marrow or Peripheral Blood Stem Cell Transplantation in Patients With Multiple Myeloma |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Drug, Procedure |
| Interventions | busulfan, melphalan, thiotepa, bone marrow transplantation, peripheral blood stem cell transplantation |
| Start date | Nov 1, 1997 |
| Primary completion | Jun 1, 2001 |
| Completion | Jun 1, 2001 |
| First posted | Apr 23, 2004 |
| Last update posted | Jun 23, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: